CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 54 filers reported holding CIDARA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $759,493 | -7.6% | 805,871 | +10.7% | 0.00% | – |
| Q2 2023 | $822,312 | -1.8% | 727,710 | +10.3% | 0.00% | – |
| Q1 2023 | $837,777 | +186903.8% | 659,667 | +11.3% | 0.00% | – |
| Q4 2022 | $448 | -99.9% | 592,724 | +1.3% | 0.00% | – |
| Q3 2022 | $367,000 | +49.8% | 584,981 | +16.5% | 0.00% | – |
| Q2 2022 | $245,000 | -38.1% | 502,049 | +5.5% | 0.00% | – |
| Q1 2022 | $396,000 | -18.2% | 476,076 | +24.8% | 0.00% | – |
| Q4 2021 | $484,000 | -43.3% | 381,618 | 0.0% | 0.00% | – |
| Q3 2021 | $854,000 | +16.2% | 381,618 | +4.8% | 0.00% | – |
| Q2 2021 | $735,000 | -53.2% | 364,162 | -38.3% | 0.00% | – |
| Q1 2021 | $1,570,000 | +72.3% | 590,368 | +29.5% | 0.00% | – |
| Q4 2020 | $911,000 | -28.6% | 455,736 | +1.7% | 0.00% | – |
| Q3 2020 | $1,276,000 | -21.2% | 448,082 | +2.1% | 0.00% | – |
| Q2 2020 | $1,619,000 | +197.1% | 438,754 | +99.4% | 0.00% | – |
| Q1 2020 | $545,000 | -39.7% | 220,009 | -6.6% | 0.00% | – |
| Q4 2019 | $904,000 | +291.3% | 235,476 | +103.0% | 0.00% | – |
| Q3 2019 | $231,000 | +106.2% | 115,992 | +73.2% | 0.00% | – |
| Q2 2019 | $112,000 | -32.1% | 66,975 | +7.5% | 0.00% | – |
| Q1 2019 | $165,000 | -43.5% | 62,280 | -50.0% | 0.00% | – |
| Q4 2018 | $292,000 | +6.6% | 124,560 | +100.0% | 0.00% | – |
| Q3 2018 | $274,000 | -15.2% | 62,280 | 0.0% | 0.00% | – |
| Q2 2018 | $323,000 | +85.6% | 62,280 | +42.5% | 0.00% | – |
| Q1 2018 | $174,000 | -41.4% | 43,691 | 0.0% | 0.00% | – |
| Q4 2017 | $297,000 | -23.5% | 43,691 | -9.0% | 0.00% | – |
| Q3 2017 | $388,000 | +8.1% | 47,992 | 0.0% | 0.00% | – |
| Q2 2017 | $359,000 | -33.8% | 47,992 | -31.0% | 0.00% | – |
| Q1 2017 | $542,000 | -24.8% | 69,547 | +0.2% | 0.00% | – |
| Q4 2016 | $721,000 | +65.4% | 69,420 | +82.2% | 0.00% | – |
| Q3 2016 | $436,000 | +16.9% | 38,110 | +5.2% | 0.00% | – |
| Q2 2016 | $373,000 | +8.7% | 36,240 | +34.1% | 0.00% | – |
| Q1 2016 | $343,000 | -24.3% | 27,025 | +2.2% | 0.00% | – |
| Q4 2015 | $453,000 | +64.7% | 26,448 | +22.0% | 0.00% | – |
| Q3 2015 | $275,000 | – | 21,687 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,172,044 | $2,625,000 | 2.31% |
| Stonepine Capital Management, LLC | 782,817 | $1,754,000 | 0.80% |
| 5AM Venture Management, LLC | 1,134,511 | $2,541,000 | 0.52% |
| Omega Fund Management, LLC | 2,005,249 | $4,492,000 | 0.50% |
| BVF INC/IL | 4,776,904 | $10,700,000 | 0.42% |
| KNOTT DAVID M | 415,308 | $930,000 | 0.34% |
| West Family Investments, Inc. | 368,910 | $826,000 | 0.21% |
| Monashee Investment Management LLC | 369,099 | $827,000 | 0.15% |
| JEPPSON WEALTH MANAGEMENT, LLC | 60,100 | $134,000 | 0.07% |
| Pacifica Partners Inc. | 8,000 | $18,000 | 0.01% |